Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence

This publication has 14 references indexed in Scilit:

• Efficacy and Safety of Transdermal Oxybutynin in Patients With Urge and Mixed Urinary Incontinence
  Journal of Urology, 2002
• A SHORT-TERM, MULTICENTER, RANDOMIZED DOUBLE-BLIND DOSE TITRATION STUDY OF THE EFFICACY AND ANTICHOLINERGIC SIDE EFFECTS OF TRANSDERMAL COMPARED TO IMMEDIATE RELEASE ORAL OXYBUTYNIN TREATMENT OF PATIENTS WITH URGE URINARY INCONTINENCE
  Journal of Urology, 2001
• Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study
  Mayo Clinic Proceedings, 2001
• Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women
  American Journal of Obstetrics and Gynecology, 2001
• Transdermal Drug Delivery Systems and Skin Sensitivity Reactions
  American Journal of Clinical Dermatology, 2000
• Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence
  Urology, 1999
• Clinical Efficacy and Safety of Tolterodine Compared to Oxybutynin and Placebo in Patients with Overactive Bladder
  International Urogynecology Journal, 1999
• ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCE
  Journal of Urology, 1999
• Behavioral vs Drug Treatment for Urge Urinary Incontinence in Older Women
  JAMA, 1998
• Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory
  Quality of Life Research, 1994